| 臺大學術典藏 |
2020-03-05T08:03:59Z |
Strong SOX10 expression in human papillomavirus–related multiphenotypic sinonasal carcinoma: report of 6 new cases validated by high-risk human papillomavirus mRNA in situ hybridization test
|
Min-Shu Hsieh;Lee Y.-H.;Jin Y.-T.;Huang W.-C.; MIN-SHU HSIEH; Lee Y.-H.; Jin Y.-T.; Huang W.-C. |
| 臺大學術典藏 |
2020-03-05T08:03:58Z |
Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes
|
Min-Shu Hsieh;Bishop J.A.;Wang Y.-P.;Poh C.F.;Cheng Y.-S.L.;Lee Y.-H.;Jin Y.-T.;Chang J.Y.F.; MIN-SHU HSIEH; Bishop J.A.; Wang Y.-P.; Poh C.F.; Cheng Y.-S.L.; Lee Y.-H.; Jin Y.-T.; Chang J.Y.F. |
| 臺大學術典藏 |
2020-03-05T08:03:58Z |
Nuclear immunoreactivity of BLM-s, a proapoptotic BCL-2 family member, is specifically detected in salivary adenoid cystic carcinoma
|
Tsai M.-S.; MIN-SHU HSIEH; Huang H.-Y.; Huang P.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:57Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Lin Y.-T.; Liu Y.-N.; Shih J.-Y.; MIN-SHU HSIEH; Gow C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:57Z |
Corrigendum to “Correlation of tumor spread through air spaces and clinicopathological characteristics in surgically resected lung adenocarcinomas” [Lung Cancer 126 (2018) 189–193](S0169500218306305)(10.1016/j.lungcan.2018.11.003)
|
Chen J.-S.; Lin M.-W.; Hu S.-Y.; MIN-SHU HSIEH; Hsu H.-H.; Tsai T.-M.; Chiang X.-H.; Tsou K.-C.; Liao H.-C. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu C.-H.; Huang T.-C.; Shao Y.-Y.; Lien M.-Y.; Kuo H.-Y.; MIN-SHU HSIEH; Lin C.-Y.; Lin C.-C.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Lin C.-Y.;Min-Shu Hsieh;Kuo H.-Y.;Lien M.-Y.;Shao Y.-Y.;Huang T.-C.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy
|
Min-Shu Hsieh;Lin M.-W.;Lee Y.-H.; MIN-SHU HSIEH; Lin M.-W.; Lee Y.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland
|
MIN-SHU HSIEH; Jeng Y.-M.; Lee Y.-H. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study
|
Ma W.-L.;Lin C.-C.;Hsu F.-M.;Lee J.-M.;Chen J.-S.;Min-Shu Hsieh;Chang Y.-L.;Chao Y.-T.;Chang C.-H.;Chih-Hsin Yang J.; Ma W.-L.; Lin C.-C.; Hsu F.-M.; Lee J.-M.; Chen J.-S.; MIN-SHU HSIEH; Chang Y.-L.; Chao Y.-T.; Chang C.-H.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-03-05T08:03:56Z |
Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
|
Yang P.-W.;Liu Y.-C.;Chang Y.-H.;Lin C.-C.;Huang P.-M.;Hua K.-T.;Lee J.-M.;Min-Shu Hsieh; Yang P.-W.; Liu Y.-C.; Chang Y.-H.; Lin C.-C.; Huang P.-M.; Hua K.-T.; Lee J.-M.; MIN-SHU HSIEH |
| 臺大學術典藏 |
2020-03-05T08:03:55Z |
Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma
|
Chiang X.-H.;Hsu H.-H.;Min-Shu Hsieh;Chang C.-H.;Tsai T.-M.;Liao H.-C.;Tsou K.-C.;Lin M.-W.;Chen J.-S.; Chiang X.-H.; Hsu H.-H.; MIN-SHU HSIEH; Chang C.-H.; Tsai T.-M.; Liao H.-C.; Tsou K.-C.; Lin M.-W.; Chen J.-S. |
| 臺大學術典藏 |
2020-03-05T08:03:55Z |
Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma
|
Kuo T.-C.;Wu M.-H.;Chen K.-Y.;Min-Shu Hsieh;Chen A.;Chen C.-N.; Kuo T.-C.; Wu M.-H.; Chen K.-Y.; MIN-SHU HSIEH; Chen A.; Chen C.-N. |
| 臺大學術典藏 |
2020-03-05T08:03:55Z |
Primary thyroid hyalinising clear cell carcinoma: a rare variant of salivary gland type carcinoma of the thyroid
|
MIN-SHU HSIEH; Chen K.-Y.; Lee Y.-H.; Wang H. |
| 臺大學術典藏 |
2019-10-23T13:07:16Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
HUNG-YANG KUO; YU-YUN SHAO; Lin, Chia Chi; Lin, Chen Yuan; Lien, Ming Yu; CHIH-HUNG HSU; Guo, Jhe Cyuan; MIN-SHU HSIEH; Huang, Ta Chen; MIN-SHU HSIEH;CHIH-HUNG HSU;YU-YUN SHAO;HUNG-YANG KUO;Huang, Ta Chen;Guo, Jhe Cyuan;Lien, Ming Yu;Lin, Chen Yuan;Lin, Chia Chi |
| 臺大學術典藏 |
2019-10-23T13:07:16Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
HUNG-YANG KUO; YU-YUN SHAO; Lin, Chia Chi; Lin, Chen Yuan; Lien, Ming Yu; CHIH-HUNG HSU; Guo, Jhe Cyuan; MIN-SHU HSIEH; Huang, Ta Chen; MIN-SHU HSIEH;CHIH-HUNG HSU;YU-YUN SHAO;HUNG-YANG KUO;Huang, Ta Chen;Guo, Jhe Cyuan;Lien, Ming Yu;Lin, Chen Yuan;Lin, Chia Chi |
| 臺大學術典藏 |
2019-09-09T00:55:35Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Gow, Chien Hung;JIN-YUAN SHIH;Liu, Yi Nan;Lin, Yen Ting;MIN-SHU HSIEH; MIN-SHU HSIEH; Lin, Yen Ting; Liu, Yi Nan; JIN-YUAN SHIH; Gow, Chien Hung |
| 臺大學術典藏 |
2019-09-09T00:55:35Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Gow, Chien Hung;JIN-YUAN SHIH;Liu, Yi Nan;Lin, Yen Ting;MIN-SHU HSIEH; MIN-SHU HSIEH; Lin, Yen Ting; Liu, Yi Nan; JIN-YUAN SHIH; Gow, Chien Hung |
| 臺大學術典藏 |
2019-03-04T08:04:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
CHONG-JEN YU; CHAO-CHI HO; WEI-YU LIAO; Lee, Jih Hsing; Tsai, Tzu Hsiu; KANG-YI SU; MIN-SHU HSIEH; YIH-LEONG CHANG; Bai, Ya Ying; Huang, Derek De Rui; Thress, Kenneth S.; CHIH-HSIN YANG; JIN-YUAN SHIH; Lin, Chia Chi; Thress, Kenneth S.;Huang, Derek De Rui;Bai, Ya Ying;Lee, Jih Hsing;Lin, Chia Chi;CHIH-HSIN YANG;YIH-LEONG CHANG;MIN-SHU HSIEH;KANG-YI SU;Tsai, Tzu Hsiu;WEI-YU LIAO;CHAO-CHI HO;CHONG-JEN YU;JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:04:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
CHONG-JEN YU; CHAO-CHI HO; WEI-YU LIAO; Lee, Jih Hsing; Tsai, Tzu Hsiu; KANG-YI SU; MIN-SHU HSIEH; YIH-LEONG CHANG; Bai, Ya Ying; Huang, Derek De Rui; Thress, Kenneth S.; CHIH-HSIN YANG; JIN-YUAN SHIH; Lin, Chia Chi; Thress, Kenneth S.;Huang, Derek De Rui;Bai, Ya Ying;Lee, Jih Hsing;Lin, Chia Chi;CHIH-HSIN YANG;YIH-LEONG CHANG;MIN-SHU HSIEH;KANG-YI SU;Tsai, Tzu Hsiu;WEI-YU LIAO;CHAO-CHI HO;CHONG-JEN YU;JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T07:58:39Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Tsai, Meng Feng;Tsai, Tzu Hsiu;Luo, Sheng Ching;Chang, Shih Han;Li, Huei Ying;Liu, Yi-Nan;Gow, Chien Hung;JIN-YUAN SHIH;PEI-LUNG CHEN;MIN-SHU HSIEH; Gow, Chien Hung; Liu, Yi-Nan; Li, Huei Ying; MIN-SHU HSIEH; Chang, Shih Han; Luo, Sheng Ching; Tsai, Tzu Hsiu; PEI-LUNG CHEN; Tsai, Meng Feng; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T07:58:39Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Tsai, Meng Feng;Tsai, Tzu Hsiu;Luo, Sheng Ching;Chang, Shih Han;Li, Huei Ying;Liu, Yi-Nan;Gow, Chien Hung;JIN-YUAN SHIH;PEI-LUNG CHEN;MIN-SHU HSIEH; Gow, Chien Hung; Liu, Yi-Nan; Li, Huei Ying; MIN-SHU HSIEH; Chang, Shih Han; Luo, Sheng Ching; Tsai, Tzu Hsiu; PEI-LUNG CHEN; Tsai, Meng Feng; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T06:51:46Z |
Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma
|
Yang, Ching-Yao;CHONG-JEN YU;JIN-YUAN SHIH;WEI-YU LIAO;MIN-SHU HSIEH; Yang, Ching-Yao; MIN-SHU HSIEH; WEI-YU LIAO; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T06:51:46Z |
Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma
|
Yang, Ching-Yao;CHONG-JEN YU;JIN-YUAN SHIH;WEI-YU LIAO;MIN-SHU HSIEH; Yang, Ching-Yao; MIN-SHU HSIEH; WEI-YU LIAO; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019 |
Thymoma-associated multiorgan autoimmunity
|
Chen J.-S.; MIN-SHU HSIEH; Tsai T.-F.; Hung C.-T.;Tsai T.-F.;Chen J.-S.;Min-Shu Hsieh; Hung C.-T. |
| 臺大學術典藏 |
2019 |
Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma
|
Yang C.-Y.; MIN-SHU HSIEH; Liao W.-Y.; Shih J.-Y.; Yu C.-J. |
